Most BPC-157 repair findings come from animals

The brief findings do not establish healing in people

A sore tendon can make a healing claim catch your eye. Amino acids are parts joined together to make a protein. BPC-157 links those parts in a 15-amino-acid chain. Researchers based the substance on part of a stomach-fluid protein.

Animal tests found less tissue damage and new blood vessels ^[4]. In 2025, a review found only three small human studies ^[2]. The reviewers read earlier papers; they didn't test injured people. No large trial compared human healing with and without the substance.

No country approves the substance as a medicine for people. Competitive sports ban the substance under World Anti-Doping Agency rules. Researchers' tested amounts don't give you a safe amount to take. Sellers supply the substance for laboratory tests, without an established human treatment.

Several research names describe the same unapproved substance

BPC-157 is also called Body Protection Compound 157. BPC 157 is another name you may find in papers. Older names include PL 14736 and PLD-116. Those names refer to a lab-made substance based on stomach-fluid protein.

A different name doesn't make the substance an approved medicine. Researchers are still studying what the substance does. None of these names gives you proof of safe treatment.

Rat ulcers shrank and blood reached injured muscle sooner

In 2004, treated rats had smaller stomach ulcers ^[5]. An ulcer is an open sore in the stomach lining. The sores healed faster, especially after shots into muscle. Putting the substance into the stomach gave less benefit.

Another study tested cells and animals with too little blood supply ^[4]. More blood vessels grew, and blood flow returned sooner. Treatment changed how cells received messages that prompt vessel growth. The study didn't show how your injured tendon would heal.

Other tests found that cells moved toward damaged tissue faster. In treated tendon cells, the response to growth hormone became stronger. That hormone carries messages helping the body grow. Researchers also found changes in chemicals affecting blood flow and nerves.

Two healthy adults cannot settle the risks for an injured person

A small safety test gave BPC-157 through a vein ^[1]. Two healthy adults received up to 20 mg, meaning milligrams. A 58-year-old man and a 68-year-old woman took part. Researchers reported no side effects or measured changes in safety tests.

Blood tests checked the heart, liver, kidneys, and blood sugar. Thyroid tests checked the gland controlling how fast the body uses energy. Those tests looked for changes after the substance was given. Nobody in this test was treated for an injury.

A 2025 review found only three small human studies ^[2]. The reviewers read papers on animal repair and human safety. Large trials comparing treated and untreated people were still missing. BPC-157 lacks approval, and sellers' products aren't checked like medicines.

Researchers measured BPC-157 in rats and beagle dogs ^[3]. Half the substance left their bodies in under 30 minutes. About 14–19% of the amount injected into rats' muscles reached their blood. About 45–51% of the amount injected into dogs' muscles reached the dogs' blood.

Larger injections produced more of the substance in the animals' blood. The substance broke down quickly into parts the body uses in proteins. The remains left in urine and bile, a digestive fluid. Those measurements don't tell you how long human healing might take.

Another study examined chick tissue, rats, and dishes holding human cells ^[4]. Those human cells came from the lining of blood vessels. The rats had too little blood reaching a back leg. BPC-157 produced more blood vessels and faster return of blood flow.

A protein receiving growth messages became more plentiful in those cells. The cells then drew that protein inside themselves. Blocking that step stopped the response that prompts vessel growth. Human cells in dishes don't show healing in an injured person.

Researchers also gave BPC-157 to rats with stomach ulcers ^[5]. Those sores inside the stomach became smaller. The lining rebuilt faster, and new tissue filled damaged areas. Your sore knee wasn't tested by that rat stomach study.

Personal reports describe both relief and unwanted effects

These are reports from people trying BPC-157 for their own problems. Their use was discussed as research, without a controlled test. These reports have no trial checking them against an untreated group. The accounts came from forums, clinic write-ups, and online reviews.

People most often described relief in joints, tendons, or ligaments. A tendon connects a muscle with a bone; ligaments steady the bones around joints. Examples included tennis elbow, shoulder strain, and old sprains. Some users felt better within the first one to three weeks.

Others described less stiffness, easier movement, or more comfortable digestion. Some said inflammation eased; inflammation is the body's response to damage. That response can cause pain, heat, redness, or swelling. Their reports didn't say which of those signs changed.

Some users thought skin or wounds healed faster than usual. Better sleep and changes in mood also appeared in accounts. Nobody compared these reports with people given an inactive treatment. You can't tell which changes came from the substance itself.

Shots sometimes left stinging, redness, or a bump that faded within a day. During the first week, some users felt sick, had stomach upset, or felt tired. Users described headaches and brief dizzy spells too. Flushing meant their skin became warm and red.

A few people reported a racing or fluttering heartbeat. People writing those accounts urged users to stop and get medical care. Reports don't establish how often these problems happen. They also don't give you a tested safe amount.

A review found far more rodent work than human testing ^[2]. One team carried out many of the earliest studies. Few other teams repeated that work to check the findings. Small tests without comparison groups leave safety and healing uncertain.

BPC-157 lacks drug approval, and bottle contents and purity aren't verified ^[2]. New blood vessels raise a possible concern during cancer ^[4]. Tumors need new blood vessels to grow as well. The concern hasn't proved harm; missing harm tests don't prove safety.

Sports rules ban the substance during competition and between events. Safety hasn't been tested in children, pregnancy, or breastfeeding. You have no study result that settles those risks. Animal healing and personal relief reports can't fill those gaps.

An animal blood-flow result cannot set your return to activity

An injured area needs blood before the tissue can rebuild. Animals grew new blood vessels in BPC-157 studies ^[4]. Earlier tests found faster repair in rats' stomach lining ^[5]. Neither finding measures how much strain your tendon can bear.

TB-500 research examines cell movement toward damaged tissue. Most of that work gave a larger protein instead. KLOW mixes both substances with other ingredients, without testing the mix. You can use the comparison page to check those different findings.